Company Filing History:
Years Active: 2003
Title: Ilan Stein: Innovator in mRNA Translation Control
Introduction
Ilan Stein is a notable inventor based in Jerusalem, Israel. He has made significant contributions to the field of molecular biology, particularly in the area of mRNA translation control. His innovative work has led to the development of a unique patent that enhances the efficiency of gene expression.
Latest Patents
Ilan Stein holds a patent for "IRES sequences with high translational efficiency and expression vectors containing the sequence." This patent describes an isolated and cloned translation control element, specifically the nucleotide sequence designated as SP163. The translation control element is designed to control cap-independent mRNA translation via an internal ribosome entry site (IRES). The invention provides expression vectors that incorporate the SP163 element operatively linked to a gene sequence intended for expression. Additionally, the patent outlines methods for facilitating and enhancing cap-independent translation of mRNA by including the translation control element in an expression cassette.
Career Highlights
Ilan Stein is associated with Qbi Enterprises Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential applications in biotechnology and therapeutic development.
Collaborations
Ilan collaborates with esteemed colleagues such as Eli Keshet and Ahuva Itin, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Ilan Stein's contributions to the field of mRNA translation control exemplify the impact of innovative thinking in biotechnology. His patent and ongoing work at Qbi Enterprises Ltd. highlight the importance of advancements in gene expression technologies.